XYL
35
-2
BK
74
3
TRIP
50
-4
BEN
50
9
NEM
40
3
WEC
53
5
HSIC
45
5
COST
57
-6
FTI
71
-7
DNB
74
-6
TXN
43
-5
FIS
51
-4
LLY
28
-8
INTC
41
4
LH
40
-5
DE
42
3
HCA
48
-2
CMI
64
-3
HRB
59
2
CMG
66
-4
XYL
35
-2
BK
74
3
TRIP
50
-4
BEN
50
9
NEM
40
3
WEC
53
5
HSIC
45
5
COST
57
-6
FTI
71
-7
DNB
74
-6
TXN
43
-5
FIS
51
-4
LLY
28
-8
INTC
41
4
LH
40
-5
DE
42
3
HCA
48
-2
CMI
64
-3
HRB
59
2
CMG
66
-4
Financhill
Back

Direxion Daily Phrmctcl&MdclBl3XShrsETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

PILL
Direxion Daily Phrmctcl&MdclBl3XShrsETF

Last Price:
8.32
Seasonality Move:
28.61%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
30
Direxion Daily Phrmctcl&MdclBl3XShrsETF (PILL) is a Sell

Is Direxion Daily Phrmctcl&MdclBl3XShrsETF a Buy, Sell or Hold?

  • The current Direxion Daily Phrmctcl&MdclBl3XShrsETF [PILL] share price is $8.34. The Score for PILL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • PILL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PILL Stock Price Chart

What is Direxion Daily Phrmctcl&MdclBl3XShrsETF's stock price today?

  • The Direxion Daily Phrmctcl&MdclBl3XShrsETF share price today is $8.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PILL is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PILL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 39.91 Sell
Chaikin Money Flow: -89347 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.87 - 9.77) Sell
Bollinger Bands (100): (7.02 - 8.98) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PILL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.57 Sell
20-day SMA: 9.29 Sell
50-day SMA: 8.68 Sell
200-day SMA: 7.71 Buy
8-day EMA: 9.27 Sell
20-day EMA: 9.23 Sell
50-day EMA: 8.78 Sell
200-day EMA: 7.93 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Direxion Daily Phrmctcl&MdclBl3XShrsETF Earnings Growth & PILL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Direxion Daily Phrmctcl&MdclBl3XShrsETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):